Tonsillitis
Drug research and approvals for tonsillitis: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.
As of Nov 18, 2026, 14 studies of tonsillitis are recruiting on ClinicalTrials.gov, and Health Canada has authorized 0 drug trials for it since 2013.
- Recruiting worldwide: 14
- Trials authorized in Canada: 0
- FDA orphan approvals: 0
- EU medicines: 0
Recruiting now
Newest start dates first, of 14 recruiting on ClinicalTrials.gov ↗- A Single Dose of Intravenous Penicillin as an Adjunct to Oral Penicillin in the Treatment of Acute Tonsillitis,…NCT07896226 · Phase 4 · Tejs Ehlers Klug · starts Nov 1, 2026
- Evaluation of Treatments for Sore Throat Associated With Acute Pharyngitis and/or Viral TonsillitisNCT07569939 · Not applicable · University Hospital, Clermont-Ferrand · starts Jul 29, 2026
- Suprazygomatic Maxillary Nerve Block in Pediatric TonsillectomyNCT07176533 · Not applicable · London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · starts Jan 1, 2026
- Perspectives on Antibiotics and Tracking Symptoms in ChildrenNCT07093749 · Not applicable · Murdoch Childrens Research Institute · starts Sep 16, 2025
- Transoral Ultrasound Versus no Transoral Ultrasound in Diagnostic Workup of Peritonsillar AbscessNCT07577232 · Not applicable · Copenhagen University Hospital, Rigshospitalet · starts Jun 9, 2025
- Trimethoprim-sulfamethoxazole vs. Clindamycin for the Treatment of Children With Invasive MRSA InfectionsNCT06982105 · Phase 4 · Indiana University · starts May 20, 2025
- SUPRATHEL 250 as a Treatment for Oropharyngeal WoundsNCT06543823 · Not applicable · Alaa Emara · starts Apr 30, 2025
- The Effect of Systemic Nonsteroidal Anti-inflammatory Drugs (NSAIDs) Vs Intraoperative Infiltration of Steroids in…NCT07035314 · Not applicable · Ain Shams University · starts Mar 8, 2025
- Optimization of Pediatric Tonsillectomy to IMprove AnaLgesiaNCT06576830 · Phase 4 · Duke University · starts Nov 21, 2024
- Complicated Infections in OtorhinolaryngologyNCT06023550 · Not reported · University Medical Centre Ljubljana · starts Sep 1, 2024
Drug pipeline
10 approved, 2 in phase 3, 12 in phase 2, 1 in phase 1 or earlier; from ChEMBL's drug indications, furthest stage reached for this conditionApproved: Amoxicillin, Telithromycin, Azithromycin, Cefaclor anhydrous, Cefuroxime axetil, Cefprozil anhydrous, (e)-, Cefdinir, Cefixime, Cefditoren pivoxil, Clarithromycin
- Penicillin g
- Phase 3 Bacterial penicillin-binding protein inhibitor
- Mikamycin
- Phase 3
- Acetaminophen
- Phase 2 Cyclooxygenase inhibitor
- Celecoxib
- Phase 2 Cyclooxygenase-2 inhibitor
- Ketorolac
- Phase 2 Cyclooxygenase inhibitor
- Midazolam
- Phase 2 GABA-A receptor; anion channel positive allosteric modulator
- Morphine
- Phase 2 Mu opioid receptor agonist
- Ondansetron
- Phase 2 Serotonin 3a (5-HT3a) receptor antagonist
- Dexamethasone
- Phase 2 Glucocorticoid receptor agonist
- Sevoflurane
- Phase 2 Glycine receptor (alpha-1/beta) positive modulator
- Propofol
- Phase 2 GABA-A receptor; anion channel positive allosteric modulator
- Fospropofol
- Phase 2 Unknown
- Oxygen
- Phase 2 Essential for cellular homeostasis
- Nitrous oxide
- Phase 2
- Lactic acid
- Phase 1 pH lowering agent
How its trials ended
98 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrongOf the 19 whose ending is known, 47% met their primary endpoint, 0% missed it and 53% stopped early.
- Completed, result not reported4142%
- Status unknown2424%
- Ongoing1414%
- Met its primary endpoint99%
- Stopped: sponsor or business decision55%
- Stopped: other or unclear44%
- Stopped: enrollment or feasibility11%
Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA